# XELJANZ
> **NDA213082** · New Drug Application · Sponsor: PFIZER · Approved 2020-09-25
## Drug
- **FDA Application Number:** NDA213082
- **Application type:** New Drug Application
- **Brand name:** XELJANZ
- **Generic name:** TOFACITINIB
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2020-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213082)
---
*AI Analytics · CC0 1.0*